Can balloon timing make or break heart artery success?

NCT ID NCT07764094

Recruiting now Knowledge-focused Sponsor: Nanjing First Hospital, Nanjing Medical University Source: ClinicalTrials.gov ↗

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study tracks 500 adults with stable coronary artery disease or unstable angina who are undergoing a heart procedure called percutaneous coronary intervention (PCI) using a drug-coated balloon. Researchers are looking at how procedural details—specifically how long the balloon takes to reach the blockage and how long it stays inflated—affect the artery's healing and future heart health. The goal is to see whether these factors influence the chance of the artery narrowing again or causing heart-related complications later on.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Drug-coated balloon
What this could lead to: If successful, this could help doctors refine how they use drug-coated balloons during heart procedures, potentially improving long-term outcomes for patients with coronary artery disease.
What could go wrong: This is an observational registry, not a controlled trial, so it can only show associations, not cause and effect. Results may be influenced by unmeasured factors and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE DRUG COATED BALLOON PCI

Contacts and locations

Locations

Nanjing First Hospital
RECRUITING

Nanjing, Jiangsu, 210006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.